Skip to main content
World Today News
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Menu
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology

Pharmacy Times: Pharmacists Use CGM Data to Spot Errors, Lifestyle Factors First

November 22, 2026 Health Desk Health

Pharmacists are using continuous glucose monitoring data to identify technique errors and lifestyle factors before medication changes are considered, Pharmacy Times reported. Joshua J. Neumiller, senior vice president of medical affairs at the American Diabetes Association, said CGM “has particularly impacted how pharmacists can support people with diabetes on a daily basis through using data to educate people about how their medications, how their physical activity and lifestyle, and other factors impact their blood glucose,” he told Pharmacy Times. The ADA’s 2026 Standards of Care note that optimal use of monitoring “requires proper review and interpretation of data,” according to the Diabetes Care publication. Not every high reading means a patient needs more medication. One patient reported painful testing; when she demonstrated her technique, pharmacist Hudspeth found she was skipping the lancing device. “She was actually taking the lancet itself and essentially jabbing it directly into her finger,” Hudspeth said. A simpler device resolved the issue. “Sometimes we assume a patient is just not adherent,” Hudspeth explained. “But the real problem, I learned, was that we hadn’t given her the right tools.”

Device factors also distort readings. The ADA lists expired or improperly stored test strips, abnormal hematocrit, and low oxygen tension at high altitude among factors affecting meter accuracy.

For CGM, patients should verify with a meter during sensor warm-up; medications including acetaminophen and vitamin C at certain doses can falsely raise sensor values depending on the sensor, and adhesive reactions warrant periodic review.

Context protects patients from unnecessary treatment changes. Nicole Paolini Albanese, clinical associate professor at the University at Buffalo School of Pharmacy and Pharmaceutical Sciences, said a prescriber might see a single 200 mg/dL reading amid 100 mg/dL values and increase medication. “You had this one 200, and you’re always 100. We need to increase your medication,” she said, describing the risk.

A patient who can explain an outlier — “This was an outlier because I was out the night before and I had a bottle of wine” — gives the provider a more accurate picture, Albanese told Pharmacy Times.

Collaborative practice agreements allow pharmacists to initiate, modify, or discontinue drug therapy under provider agreements.

“We know that important gaps exist in use of evidence-based therapies in diabetes, and pharmacists are well positioned to intervene and address gaps related to education, care coordination, access to therapies and technologies, and optimization of guideline-directed therapy,” Neumiller said. He sees pharmacists “positioned as a central member of the care team, regardless of practice setting.”

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related reading

  • Beaver Moon Starts Three Supermoons Nov. 24, Includes Christmas Eve
  • Author Publishes 370 Books in 20 Months Using Multi-Model AI Workflow
  • Dollar General's Four Test Buys: 30 Price Errors, 21 Against the Shopper (daybreakwire.com)

Related

Search:

World Today News

World Today News is your trusted source for global journalism — breaking headlines, in-depth analysis, and reporting from around the world.

Quick Links

  • Privacy Policy
  • About Us
  • Accessibility statement
  • California Privacy Notice (CCPA/CPRA)
  • Contact
  • Cookie Policy
  • Disclaimer
  • DMCA Policy
  • Do not sell my info
  • EDITORIAL TEAM
  • Terms & Conditions

Browse by Location

  • GB
  • NZ
  • US

Connect With Us

© 2026 World Today News. All rights reserved. Your trusted global news source directory.
For contact, advertising, copyright, issues email: [email protected]

Privacy Policy Terms of Service